About Bluepha
Bluepha is a company based in Beijing (China) founded in 2016. Bluepha has raised $133.02 million across 8 funding rounds from investors including SVB, China Merchants Bank and China Renaissance Group. Bluepha operates in a competitive market with competitors including Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
- Headquarter Beijing, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$133.02 M (USD)
in 8 rounds
-
Latest Funding Round
$58.64 M (USD), Series B
Feb 15, 2023
-
Investors
SVB
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Bluepha
Unlock access to complete
Unlock access to complete
Funding Insights of Bluepha
Bluepha has successfully raised a total of $133.02M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $58.64 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bluepha
Bluepha has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, China Merchants Bank and China Renaissance Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Financial services are provided by Huanghai Financial Holdings in China.
|
Locked | Locked | Locked | |
|
Tech focused VC firm investing in early stage companies in the US & China
|
Locked | Locked | Locked |
Investor details for Bluepha
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bluepha
Investment portfolio details for Bluepha
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bluepha
Detailed financials for Bluepha
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bluepha Comparisons
Peer comparison for Bluepha
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bluepha
Bluepha operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| Locked | Locked | Locked |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
Detailed competitors of Bluepha
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bluepha
Complete news archive for Bluepha
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bluepha
Bluepha was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Bluepha is headquartered in Beijing, China.
Bluepha is a funded company, having raised a total of $133.02M across 8 funding rounds to date.
Bluepha was founded in 2016 in Beijing, China, and operates within the synthetic biology sector. Microbial manufacturing technology is utilized to create bio-based products applicable to industries such as consumer goods, healthcare, specialty chemicals, agriculture, and electronics. Development efforts focus on biomaterials that support diverse applications across these fields.
Bluepha has 17 investors. Key investors include SVB, China Merchants Bank, China Renaissance Group, 碧桂园, and Zhongping Capital.